797 related articles for article (PubMed ID: 15907412)
1. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Rahmani M; Raiszadeh F; Allahverdian S; Kiaii S; Navab M; Azizi F
Atherosclerosis; 2002 Jun; 162(2):381-9. PubMed ID: 11996958
[TBL] [Abstract][Full Text] [Related]
3. Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk.
van der Steeg WA; Boekholdt SM; Stein EA; El-Harchaoui K; Stroes ES; Sandhu MS; Wareham NJ; Jukema JW; Luben R; Zwinderman AH; Kastelein JJ; Khaw KT
Ann Intern Med; 2007 May; 146(9):640-8. PubMed ID: 17470832
[TBL] [Abstract][Full Text] [Related]
4. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of apolipoproteins A-1 and B in Indian patients with angiographically defined coronary artery disease.
Bahl VK; Vaswani M; Thatai D; Wasir HS
Int J Cardiol; 1994 Sep; 46(2):143-9. PubMed ID: 7814163
[TBL] [Abstract][Full Text] [Related]
6. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
[TBL] [Abstract][Full Text] [Related]
7. Correlation of lipoprotein (a) to angiographically defined coronary artery disease in Indians.
Gupta R; Vasisht S; Bahl VK; Wasir HS
Int J Cardiol; 1996 Dec; 57(3):265-70. PubMed ID: 9024915
[TBL] [Abstract][Full Text] [Related]
8. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans.
Sung KC; Hwang ST
Atherosclerosis; 2005 May; 180(1):161-9. PubMed ID: 15823289
[TBL] [Abstract][Full Text] [Related]
9. Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction.
Goswami B; Rajappa M; Mallika V; Kumar S; Shukla DK
Acta Cardiol; 2008 Dec; 63(6):749-55. PubMed ID: 19157171
[TBL] [Abstract][Full Text] [Related]
10. Apolipoproteins: correlation with carotid intimamedia thickness and coronary artery disease.
Jadhav UM; Kadam NN
J Assoc Physicians India; 2004 May; 52():370-5. PubMed ID: 15656025
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein B and coronary artery disease in women: a cross-sectional study in women undergoing their first coronary angiography.
Westerveld HT; van Lennep JE; van Lennep HW; Liem AH; de Boo JA; van der Schouw YT; Erkelens DW
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1101-7. PubMed ID: 9672070
[TBL] [Abstract][Full Text] [Related]
12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.
Ishikawa T; Ayaori M; Uto-Kondo H; Nakajima T; Mutoh M; Ikewaki K
Atherosclerosis; 2015 Sep; 242(1):318-22. PubMed ID: 26246268
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of lipids and apolipoproteins in angiographycally defined ischemic heart disease.
Shima K; Tanaka A; Ejiri N; Maezawa H
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):169-77. PubMed ID: 3865743
[TBL] [Abstract][Full Text] [Related]
15. Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Azizi F; Rahmani M; Raiszadeh F; Solati M; Navab M
Coron Artery Dis; 2002 Feb; 13(1):9-16. PubMed ID: 11917194
[TBL] [Abstract][Full Text] [Related]
16. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
17. Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease.
Lee BJ; Lin JS; Lin YC; Lin PT
Lipids Health Dis; 2016 Jun; 15():107. PubMed ID: 27317162
[TBL] [Abstract][Full Text] [Related]
18. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
20. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
